Replies to post #88014 on Biotech Values

[DewDiligence]

MDCO’s CC re in-licensing of PFE’s ApoA1 Milano was notable in that MDCO’s executives could be heard openly laughing at some of the CC questions. Worth a listen, IMO, for entertainment value as well as investment value.

Webcast link:
http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-EventDetails&EventId=2623623

Slides:
http://www.themedicinescompany.com/pdf/MDCO%20-%20ApoA-I%20Milano%20Acquisition.pdf

[DewDiligence]

MDCO drops ApoA-1 Milano program:

http://finance.yahoo.com/news/medicines-company-discontinues-development-mdco-213000488.html

This program was acquired from PFE in 2009 was a paltry $10M up-front (#msg-44785558).